All Posts By

Ben Kemp

NICE: Interim methods and processes for Late Stage Assessment (LSA) in HealthTech ConsultationsConsultations Archive

NICE: Interim methods and processes for Late Stage Assessment (LSA) in HealthTech

You can now review and comment on the interim methods and process statement for Late Stage Assessment (LSA) in HealthTech. Documents to comment on: Interim methods and process statement for late-stage assessment (LSA) in healthtech Equality and health inequalities assessment The consultation closes on Thursday 28th March 2024 at 17:00
Ben Kemp
March 6, 2024
BIVDA respond to election-year Budget Membership NewsMembership News Archive

BIVDA respond to election-year Budget

BIVDA note with interest today’s election-year Budget. As expected, the Budget was light on impact for the life sciences and medical diagnostic sectors and focussed on election-year issues. Funding £45m into medical research, including £3m ringfenced for cancer, is welcome but relatively low impact. An investment of £650m into the Cambridge Biomedical Campus and a vaccine hub in Speke by…
Ben Kemp
March 6, 2024
Media Monitoring: 29 February – 6 March HighlightsHighlights Archive

Media Monitoring: 29 February – 6 March

Investigation into the UKHSA’s health security campus programme The UK Health Security Agency’s (UKHSA’s) health security campus programme aims to enhance and replace UKHSA infrastructure, most importantly its high-containment laboratories, which are essential for protecting the nation against potentially highly infectious diseases Replacing and modernising UKHSA’s facilities through the programme is of crucial importance to ensure the UK has the…
Ben Kemp
March 6, 2024
Evidence given in Parliament on lessons learned from the pandemic HighlightsHighlights Archive

Evidence given in Parliament on lessons learned from the pandemic

In the latest Health and Social Care Committee hearing, Professor Sir John Bell and Professor Dame Jenny Harries, Chief Executive of UKHSA, provided their thoughts on how the UK is preparing for future pandemics and what lessons have been learnt over the last four years. In the first session, Professor Bell outlined his fears that, should a more deadly pandemic…
Ben Kemp
March 6, 2024
Chancellor pledges millions to life sciences industry in pre-Budget announcement HighlightsHighlights Archive

Chancellor pledges millions to life sciences industry in pre-Budget announcement

Two days before the Budget, the Chancellor, Jeremy Hunt, announced a £92 million joint government and industry investment to expand facilities to manufacture life-saving medicines and diagnostics products. This was part of an overall £360 million package to boost British manufacturing and R&D. It is expected that this good news for the sector has been trailed so as not to…
Ben Kemp
March 6, 2024
Commercial partner needed for novel sudden cardiac death diagnostic test Membership NewsMembership News Archive

Commercial partner needed for novel sudden cardiac death diagnostic test

Dr Angeliki Asimaki, Senior Lecturer in Sudden Death based at St George’s, University of London, is seeking a commercial partner or support organisation for her test to diagnose risk of sudden cardiac death. Dr Asimaki studies a disease called arrhythmogenic cardiomyopathy, one of the major causes of sudden death in all populations of the world. Currently, there is no gold…
Ben Kemp
March 6, 2024
Barclays Eagle Labs funding and support programmes Membership NewsMembership News Archive

Barclays Eagle Labs funding and support programmes

Barclays Eagle Labs, who are partnered with BIVDA’s Springboard programme, have two programmes open which may be of interest to BIVDA members: Funding Readiness Programme The Funding Readiness Programme helps companies to improve their knowledge of the funding landscape, learn about the available innovation grant funds, how to develop a compelling grant application, and understand how to plan, market and…
Ben Kemp
March 6, 2024
Free hybrid event: Novel Diagnostics for Infectious Diseases, 25-26 March Membership NewsMembership News Archive

Free hybrid event: Novel Diagnostics for Infectious Diseases, 25-26 March

Head to the Royal Society, or watch online, for this free event, which will examine common challenges shared by diagnostics developers. It has been organised by Imperial College London’s Institute of Infection, B2B2B Network, London In Vitro Diagnostics Co-operative and NIHR Biomedical Research Centre. Through presentations and panel discussions, attendees will explore topics such as Technologies and Challenges, Regulatory and Adoption…
Ben Kemp
March 6, 2024
BIVDA attends the Academy of Medical Sciences FORUM workshop on early detection of neurodegenerative diseases Membership NewsMembership News Archive

BIVDA attends the Academy of Medical Sciences FORUM workshop on early detection of neurodegenerative diseases

Last week, BIVDA’s Innovation Programme Lead Lucy Lehane, attended a workshop focussing on the early detection of neurodegenerative diseases in primary care and the community. The Academy of Medical Sciences, Alzheimer’s Research UK, and Alzheimer’s Society jointly hosted the workshop, and the audience included a number of people with lived experience of neurodegenerative conditions alongside experts from across neurology, brain…
Ben Kemp
March 6, 2024